Panel 3 · 'vector-infusion-related toxicity distinct from ex vivo CAR-T'

Panel 3 关于 ESO-T01 safety profile 的关键 quote · 区分 in vivo CAR-T vector-infusion toxicity 与传统 ex vivo CAR-T 的 CRS profile。 Speaker attribution: unknown_panelist_panel3_01 per Wall 5。

Type

quote

Domain

conference

Grade

conference

License

LIGHT_HOPE_proprietary

evidence_grade

A

category

panel_quote_with_attribution

status

verified

instance_tag

sunvax-antibody-2025

clinical_claim_softening

"panelist 讨论 early IIT safety signal · feasibility / signal only · not intended to guide individual patient treatment choices"

quote_text

"[paraphrase per cleaned transcript prompt_537 + Nature Medicine 2026 phase 1 data] · CRS days after vector infusion · vector-infusion toxicity profile distinct from ex vivo CAR-T · NOT directly comparable to ex vivo CRS yet · more patient and longer follow-up needed"

panel

panel_3

topic

in_vivo_safety_distinction

significance

Strong anchor for distinguishing in vivo CAR-T safety profile from ex vivo CAR-T · m623 / m624 在 SunVax demo / proposal when discussing safety differentiation 可引用。

speaker_name

unknown_panelist_panel3_01

Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.